全文获取类型
收费全文 | 12802篇 |
免费 | 1066篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 548篇 |
妇产科学 | 322篇 |
基础医学 | 1497篇 |
口腔科学 | 178篇 |
临床医学 | 1888篇 |
内科学 | 2328篇 |
皮肤病学 | 463篇 |
神经病学 | 936篇 |
特种医学 | 347篇 |
外科学 | 1514篇 |
综合类 | 231篇 |
一般理论 | 17篇 |
预防医学 | 1522篇 |
眼科学 | 188篇 |
药学 | 721篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 1067篇 |
出版年
2022年 | 89篇 |
2021年 | 201篇 |
2020年 | 115篇 |
2019年 | 220篇 |
2018年 | 229篇 |
2017年 | 197篇 |
2016年 | 216篇 |
2015年 | 212篇 |
2014年 | 301篇 |
2013年 | 478篇 |
2012年 | 669篇 |
2011年 | 730篇 |
2010年 | 411篇 |
2009年 | 358篇 |
2008年 | 719篇 |
2007年 | 723篇 |
2006年 | 725篇 |
2005年 | 682篇 |
2004年 | 648篇 |
2003年 | 646篇 |
2002年 | 588篇 |
2001年 | 239篇 |
2000年 | 262篇 |
1999年 | 253篇 |
1998年 | 134篇 |
1997年 | 146篇 |
1996年 | 147篇 |
1995年 | 127篇 |
1994年 | 96篇 |
1993年 | 97篇 |
1992年 | 175篇 |
1991年 | 194篇 |
1990年 | 189篇 |
1989年 | 163篇 |
1988年 | 199篇 |
1987年 | 173篇 |
1986年 | 139篇 |
1985年 | 185篇 |
1984年 | 128篇 |
1983年 | 132篇 |
1982年 | 91篇 |
1981年 | 77篇 |
1979年 | 120篇 |
1978年 | 118篇 |
1977年 | 84篇 |
1976年 | 79篇 |
1975年 | 81篇 |
1974年 | 98篇 |
1973年 | 105篇 |
1972年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
3.
4.
5.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献
6.
7.
8.
Heung Bae Kim James J Pomposelli Craig W Lillehei Roger L Jenkins Maureen M Jonas Laura E Krawczuk Steven J Fishman 《Liver transplantation》2005,11(11):1389-1394
Extrahepatic portal vein thrombosis (EHPVT) may occur in children or adults and usually comes to clinical attention due to complications of portal hypertension such as variceal hemorrhage. A variety of standard surgical techniques exist to manage these patients, but when these fail surgical options are limited. We describe two novel portosystemic shunts that utilize the gonadal vein as an autologous conduit. Four patients were evaluated for EHPVT with variceal bleeding. None of the patients were candidates for a standard splenorenal shunt due to prior surgical procedures. The first patient underwent a left mesogonadal shunt and the remaining 3 patients underwent a right mesogonadal shunt. Postoperative ultrasound or computed tomography (CT) scan confirmed early patency of the shunt in each patient. There have been no further episodes of variceal hemorrhage with follow-up of 3.5 years in the child who underwent the left mesogonadal shunt, and 17, 19, and 20 months in the patients who underwent the right mesogonadal shunt. Three of the 4 shunts remain patent. One shunt thrombosis occurred in a patient homozygous for the Factor V Leiden mutation despite anticoagulation with coumadin. This is the first report of the successful use of the gonadal vein as an in situ conduit for constructing a portosystemic shunt. In conclusion, the right and left mesogonadal shunts may be useful as salvage operations for patients with EHPVT who have failed standard surgical shunt procedures. 相似文献
9.
The use of N-acetylcysteine has increased in the prevention of radiographic contrast induced nephrotoxicity. Many nurses need to be aware of the proper administration and action of this prophylactic agent. This article discusses the research behind the use of N-acetylcysteine and the protocol for administration to prevent radiographic contrast-induced nephrotoxicity. 相似文献
10.
Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C – preliminary report 下载免费PDF全文
Donald H Marks Mehdi Adineh Binquan Wang Sudeepa Gupta 《Neuropsychiatric Disease and Treatment》2007,3(5):655-667
Interferon alfa2 (IFN-α2) is a parenterally administered cytokine used to treat patients with Hepatitis C and B, and malignancy. Interferon (INF) has a relatively high rate of central nervous system (CNS) adverse effects, including agitation, depression, fatigue, cognitive dysfunction, suicidal thought and drug craving. Using functional magnetic resonance imaging (fMRI) we studied patients with Hepatitis C virus (HCV) infection who were not more than mildly clinically depressed at baseline for their CNS reaction to IFN-α2. During fMRI, patients underwent visual stimulation with pictures designed to induce feelings of depression. In the two patients who became clinically depressed or markedly anxious while on treatment with interferon, but not in patients who did not experience these effects, there was a significant activation in specific areas of the brain known to be involved with depression, along with an increase above baseline in the Beck Depression Scale for the patient who developed INF-induced depression. The activation pattern differed from that previously observed for endogenous depression, indicating that INF-induced depression may differ in its underlying neuropathology. Functional magnetic resonance imaging can be an important tool in understanding and monitoring for (INF and other) medication-induced CNS effects, and response to treatment. 相似文献